Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Wednesday, December 16, 2009, 9:02AM ET - U.S. Markets open in 28 mins.. Dow Down 0.47% Nasdaq  0.00%
Neostem, Inc. (NBS)On Dec 15: 1.65   0.00 (0.00%)  
MORE ON NBS
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Neostem, Inc.
420 Lexington Avenue
Suite 450
New York, NY 10170
United States - Map
Phone: 212-584-4180
Fax: 646-514-7787
Web Site: http://www.neostem.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Specialized Health Services
Full Time Employees:11

BUSINESS SUMMARY 
NeoStem, Inc., together with its subsidiaries, operates a network of commercial autologous adult stem cell banks in the metropolitan areas of the United States. It provides adult stem cell processing, collection, cryopreservation, and banking services. Stem cells are used to treat various serious diseases and conditions, including cardiac disease, autoimmune disorders, lupus, multiple sclerosis, peripheral vascular diseases, age related musculoskeletal disorders, diabetes, cancer, neurological disease, and wound healing. The company has a strategic alliance with New England Cryogenic Center, Inc. to provide processing and storage capacity for consumers on the East Coast, and process and store for research purposes; and with UTEK Corporation to identify and isolate stem cells from adult human bone marrow called very small embryonic-like stem cells. The company was formerly known as Phase III Medical, Inc. and changed its name to Neostem, Inc. in 2006. NeoStem, Inc. is headquartered in New York, New York.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Neostem, Inc.


    CORPORATE GOVERNANCE 
    Neostem, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 51.9% of CGQ Universe companies and 26.1% of Insurance companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Dr. Robin L. Smith M.D., MBA, 44
    Exec. Chairman and Chief Exec. Officer
    $ 511.00KN/A
    Ms. Catherine M. Vaczy Esq., 47
    VP, Sec. and Gen. Counsel
    N/A N/A
    Dr. Denis O. Rodgerson Ph.D., 75
    Founder of Stem Cell Science
    N/A N/A
    Mr. Larry A. May , 59
    Chief Financial Officer and Principal Accounting Officer
    N/A N/A
    Ms. Lepore Teresa Linn Samuels ,
    VP of Sales and Marketing
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis